Next Article in Journal
Six Cases of Autoimmune Acquired Coagulation Factor VIII Deficiency: Single Center Experience in Japan
Previous Article in Journal
Advancing Leukemia Diagnostics: Role of Next Generation Sequencing (NGS) in Acute Myeloid Leukemia
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Hematology Reports
Volume 12
Issue 2
10.4081/hr.2020.8995
hematolrep-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Hematology Reports is published by MDPI from Volume 14 Issue 1 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with PAGEPress.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Erratum

ERRATUM: A Unique Case of Durable Complete Remission after Salvage with Azacitidine and DLI for High Risk Flt-3 Positive Acute Myeloid Leukemia, Following Relapse 18 Months Post Allogeneic Stem Cell Transplant

by
Claire Horgan
,
Alexandros Kanellopoulos
,
Shankara Paneesha
,
Bhuvan Kishore
,
Richard Lovell
and
Emmanouil Nikolousis
*
Hematology and Stem Cell Transplantation Department, Heart of England NHS Trust, Birmingham AL 30511, UK
*
Author to whom correspondence should be addressed.
Hematol. Rep. 2020, 12(2), 8995; https://doi.org/10.4081/hr.2020.8995
Submission received: 16 November 2020 / Revised: 16 November 2020 / Accepted: 16 November 2020 / Published: 16 November 2020

Excerpt

Note: In lieu of an abstract, this is an excerpt from the first page.

Due to an error, Dr. Nikolousis’s last name was mistakenly spelled in this article (published in 2019 in Hematology Reports DOI: 10.4081/hr.2019.7800) [...]

Share and Cite

MDPI and ACS Style

Horgan, C.; Kanellopoulos, A.; Paneesha, S.; Kishore, B.; Lovell, R.; Nikolousis, E. ERRATUM: A Unique Case of Durable Complete Remission after Salvage with Azacitidine and DLI for High Risk Flt-3 Positive Acute Myeloid Leukemia, Following Relapse 18 Months Post Allogeneic Stem Cell Transplant. Hematol. Rep. 2020, 12, 8995. https://doi.org/10.4081/hr.2020.8995

AMA Style

Horgan C, Kanellopoulos A, Paneesha S, Kishore B, Lovell R, Nikolousis E. ERRATUM: A Unique Case of Durable Complete Remission after Salvage with Azacitidine and DLI for High Risk Flt-3 Positive Acute Myeloid Leukemia, Following Relapse 18 Months Post Allogeneic Stem Cell Transplant. Hematology Reports. 2020; 12(2):8995. https://doi.org/10.4081/hr.2020.8995

Chicago/Turabian Style

Horgan, Claire, Alexandros Kanellopoulos, Shankara Paneesha, Bhuvan Kishore, Richard Lovell, and Emmanouil Nikolousis. 2020. "ERRATUM: A Unique Case of Durable Complete Remission after Salvage with Azacitidine and DLI for High Risk Flt-3 Positive Acute Myeloid Leukemia, Following Relapse 18 Months Post Allogeneic Stem Cell Transplant" Hematology Reports 12, no. 2: 8995. https://doi.org/10.4081/hr.2020.8995

APA Style

Horgan, C., Kanellopoulos, A., Paneesha, S., Kishore, B., Lovell, R., & Nikolousis, E. (2020). ERRATUM: A Unique Case of Durable Complete Remission after Salvage with Azacitidine and DLI for High Risk Flt-3 Positive Acute Myeloid Leukemia, Following Relapse 18 Months Post Allogeneic Stem Cell Transplant. Hematology Reports, 12(2), 8995. https://doi.org/10.4081/hr.2020.8995

Article Metrics

Back to TopTop